CD14 and type 2 diabetes mellitus: Within a subgroup of individuals (8 healthy control individuals, 13 individuals with T2DM without MVD, 7 individuals with T2DM with CAD, and 5 individuals with T2DM with PAD), the percentage of Tie2+ monocytes within the total monocyte population and the various CD14/CD16 monocyte subsets was quantified.